SC Infliximab Retreatment Shows Sustained Efficacy After Drug Holiday
SC infliximab retreatment has demonstrated the ability to restore and maintain disease control in patients with inflammatory bowel disease after a treatment interruption. New findings from Celltrion, Inc. show...

